BIAFW vs NWSA · rev $6.2M vs rev $9.03B
bioAffinity Technologies Inc. Warrant (BIAFW) versus NWSA (NWSA) — a side-by-side from cached financials, not a winner call.
bioAffinity Technologies Inc. Warrant (BIAFW) common stock listed on US.
NWSA (NWSA) common stock.
Latest reported BIAFW revenue for 2025-12-31 was $6.2M. Net income was -$14.9M. Revenue was down 34.2% from 2024-12-31 to 2025-12-31. BIAFW currently screens at market cap $0.
Latest reported NWSA revenue for 2026-06-30 was $9.03B. Net income was $573.0M. Revenue was up 328.1% from 2025-06-30 to 2026-06-30. NWSA currently screens at market cap $0.
BIAFW currently screens at market cap $0. NWSA currently screens at market cap $0.
Not investment advice. Open the BIAFW and NWSA stock pages for the full models.
Not investment advice.